Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are not predictive of pathologic complete response to neoadjuvant chemotherapy in triple-negative breast cancer

• Autor(es): Pinho, I. Soares de ; Barroso, T. ; Trabulo, C. ; Campoa, E. ; Patel, V. ; Gonçalves, L. ; Araújo, J. ; Monteiro, C. ; Ferreira, A. ; Machado, B. ; Dâmaso, S. ; Luz, P. ; Sousa, R. Teixeira de ; Costa, L.
• Data: 2023
• Identificador Persistente: http://hdl.handle.net/10400.1/26881
• Origem: Sapientia - Universidade do Algarve
• Tipo de Documento: Objeto de conferência
• Idioma: Inglês
• Contribuidor(es): Sapientia

Descrição

Pathological complete response (pCR) to neoadjuvant chemotherapy (NAChT) has been validated as a predictor of long-term survival in breast cancer (BC), especially in triple-negative breast cancer (TNBC)